Content about Sexuality

August 7, 2013

Teva Women’s Health, the U.S subsidiary of Teva Pharmaceuticals, announced on Wednesday that the emergency contraceptive Plan B One-Step (levonorgestrel) tablet 1.5 mg is now widely available at retail with no age or point-of-sale restrictions.

NORTH WALES, Pa. — Teva Women’s Health, the U.S subsidiary of Teva Pharmaceuticals, announced on Wednesday that the emergency contraceptive Plan B One-Step (levonorgestrel) tablet 1.5 mg is now widely available at retail with no age or point-of-sale restrictions. Plan B One-Step marks the first emergency contraceptive to be available for OTC sale to all consumers.

May 7, 2013

According to a recent Prevention survey, 74% of women are interested in knowing more about how their digestive system works, but almost half surveyed believe that digestive health is a taboo subject people are uncomfortable discussing.

CINCINNATI — According to a recent Prevention survey, 74% of women are interested in knowing more about how their digestive system works, but almost half surveyed believe that digestive health is a taboo subject people are uncomfortable discussing.

“This survey clearly shows there are many women across the country who struggle to maintain digestive balance, but they’re a little embarrassed to talk about it,” stated Siobhan O’Connor, executive editor of Prevention and Prevention.com.  

December 28, 2012

Mylan on Friday announced that its partner Famy Care has received final approval from the Food and Drug Administration for its abbreviated new drug application for levonorgestrel and ethinyl estradiol Tablets USP in the 0.15mg/0.03mg strength.

PITTSBURGH — Mylan on Friday announced that its partner Famy Care has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for levonorgestrel and ethinyl estradiol tablets USP in the 0.15mg/0.03mg strength.

The product is a generic version of Teva Branded Pharmaceutical Products' Nordette 28 Tablets, a form of oral contraception. The new product will be distributed in the United States by Mylan Pharmaceuticals, and the company is shipping the product immediately.

February 4, 2011

A private entrepreneur is close to introducing a take-home intracervical insemination fertilization kit to retail, according to a story published in the Pittsburgh Post-Gazette Friday.

PITTSBURGH — A private entrepreneur is close to introducing a take-home intracervical insemination fertilization kit to retail, according to a story published in the Pittsburgh Post-Gazette Friday. The product will be submitted for Food and Drug Administration approval in the first half of 2011. If approved, Steve Bollinger first plans to introduce the product into doctor’s offices before launching through retail pharmacy.